NEWS

Damartex
news

Turnover for the 2nd quarter of the 2022/2023 financial year

Agility and Strong Fundamentals in a Still Challenging Environment Damartex ended the first half of the 2022/2023 financial year with sales of €364.6 Mn, down on the previous year (-9.2% at actual exchange rates, -9.1% at like for like exchange rates). In a context marked by inflation and the decline in purchasing power, sales amounted […]

Read more
Extra-Financial Performance Statement

The Extra-Financial Performance Statement presents the strategy and CSR indicators of the Damartex Group. It is published every year, after an external audit. Damartex has formalised its CSR policy, Change Our World, around three pillars: planet, ethics and solidarity. Commitment to the planet We have measured the carbon footprint of the entire value chain (scope […]

Read more
Turnover of the 1st quarter of the 2022/2023 Financial Year

Group Agility in a Still Deteriorated Economic Environment  In the first quarter of the 2022/2023 Financial year, the Damartex Group’s revenues amounted to €135.4 Mn, down -13.7% at actual exchange rates compared with the 1st quarter of 2021/2022 (-13.8% at like for like exchange rates). Over this period, the Group recruited 302,000 new customers. This […]

Read more
Acquisition of Icelus Médical

Strengthening of Santéol in the Paris Region The Damartex group announces the acquisition of 100% of the shares of the ADS company by Santéol holding. This operation, like the previous ones, is part of the implementation of the Group’s transformation plan “Transform to Accelerate – TTA 2.0”. The ADS company, a home healthcare provider (so-called […]

Read more
Turnover of the 2021/2022 financial year

Progress of the TTA 2.0 Transformation Plan Slowdown in Business in an Inflationary Context Damartex closed the 2021/2022 fiscal year with sales of €719.0 million, down -5.9% at actual rates compared with the previous year (-7.1% at like for like exchange rates), impacted by a difficult economic context. After a stable first half compared with the […]

Read more
Acquisition of the Médical Santé Group

Further development in the “Healthcare” sector and restructuring of the homecare (MAD) activity As part of its ‘Transform To Accelerate – TTA 2.0’ transformation plan, the Damartex group announced its acquisition of 100% of the shares in the Médical Santé group, thereby reinforcing its position as a European leader in the Silver Economy. Created in […]

Read more
Turnover of the First Nine Months of the 2021/2022 Financial Year

Continuation of the Group’s Transformation Plan Despite an Uncertain and Inflationary Environment Damartex closed the third quarter with sales of € 173.0 Mn, down -11.3% at actual exchange rates (down -12.5% at like for like exchange rates) compared with the third quarter of the previous financial year. The Group’s business is suffering from record inflation, […]

Read more
Acquisition of the company JP Consult

The Damartex group announces the acquisition of 100% of the shares of the company JP Consult by the company Santéol Holding. This operation, like that of Perf R in Île de France recently, is part of the group’s transformation plan: “Transform To Accelerate – TTA 2.0”. JP Consult is a home health care provider (PSAD) […]

Read more
Acquisition of the company PERF R

As part of its “Transform To Accelerate – TTA 2.0” transformation plan, the Damartex group announces the acquisition of 100% of the shares of the company Perf R by the company Santéol île de France. The company Perf R, a home health care provider specialising in respiratory assistance, is based in Palaiseau in Ile-de-France. Perf […]

Read more